Story perspectives

Geneticist Advocates African Genomes for Sickle Cell Treatments

9/18/2025

50 10

Summary

Story summary

Dr. Ambroise Wonkam, a geneticist from Cameroon, heads the McKusick-Nathans Institute at Johns Hopkins University.
He investigates genetic variations in African populations, particularly sickle cell disease and its modifiers.
Sickle cell disease, linked to a hemoglobin mutation, severely affects children in Nigeria, leading to high mortality rates.
Wonkam identifies genes such as APOL1 and FLT1, which may inform new treatments.
He advocates for incorporating African genomes in genetic research to enhance global health outcomes.

1 of 1

Story summary

Dr. Ambroise Wonkam, a geneticist from Cameroon, heads the McKusick-Nathans Institute at Johns Hopkins University.
He investigates genetic variations in African populations, particularly sickle cell disease and its modifiers.
Sickle cell disease, linked to a hemoglobin mutation, severely affects children in Nigeria, leading to high mortality rates.
Wonkam identifies genes such as APOL1 and FLT1, which may inform new treatments.
He advocates for incorporating African genomes in genetic research to enhance global health outcomes.